14-3-3σ stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion

被引:54
作者
Boudreau, Aaron [1 ]
Tanner, Kandice [1 ]
Wang, Daojing [1 ]
Geyer, Felipe C. [2 ]
Reis-Filho, Jorge S. [2 ]
Bissell, Mina J. [1 ]
机构
[1] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA
[2] Inst Canc Res, Mol Pathol Lab, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England
关键词
cytoskeleton; motility; 14-3-3; family; triple-negative; basal breast cancer; GENE-EXPRESSION SIGNATURE; EPITHELIAL-CELLS; SACCHAROMYCES-CEREVISIAE; XENOGRAFT MODEL; IN-SITU; CANCER; PROTEINS; PROGRESSION; STRESS; CYTOSKELETON;
D O I
10.1073/pnas.1315022110
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The protein 14-3-3s (stratifin) is frequently described as a tumor suppressor silenced in about 80% of breast tumors. Intriguingly, we show that 14-3-3s expression, which in normal breast is localized to the myoepithelial cells, tracks with malignant phenotype in two models of basal-like breast cancer progression, and in patients, it is associated with basal-like subtype and poor clinical outcome. We characterized a mechanism by which 14-3-3s guides breast tumor invasion by integrating cytoskeletal dynamics: it stabilizes a complex of solubilized actin and intermediate filaments to maintain a pool of "bioavailable"complexes for polarized assembly during migration. We show that formation of the actin/cytokeratin/ 14-3-3s complex and cellular migration are regulated by PKC.dependent phosphorylation, a finding that could form the basis for intervention in aggressive breast carcinomas expressing 14-33s. Our data suggest that the biology of this protein is important in cellular movement and is contingent on breast cancer subtype.
引用
收藏
页码:E3937 / E3944
页数:8
相关论文
共 54 条
[31]   Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma [J].
Nielsen, TO ;
Hsu, FD ;
Jensen, K ;
Cheang, M ;
Karaca, G ;
Hu, ZY ;
Hernandez-Boussard, T ;
Livasy, C ;
Cowan, D ;
Dressler, L ;
Akslen, LA ;
Ragaz, J ;
Gown, AM ;
Gilks, CB ;
van de Rijn, MV ;
Perou, CM .
CLINICAL CANCER RESEARCH, 2004, 10 (16) :5367-5374
[32]   Nucleating actin for invasion [J].
Nurnberg, Alexander ;
Kitzing, Thomas ;
Grosse, Robert .
NATURE REVIEWS CANCER, 2011, 11 (03) :177-187
[33]  
PARDEE JD, 1982, METHOD ENZYMOL, V85, P164
[34]   Systems Biology and Genomics of Breast Cancer [J].
Perou, Charles M. ;
Borresen-Dale, Anne-Lise .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2011, 3 (02) :1-17
[35]   Molecular portraits of human breast tumours [J].
Perou, CM ;
Sorlie, T ;
Eisen, MB ;
van de Rijn, M ;
Jeffrey, SS ;
Rees, CA ;
Pollack, JR ;
Ross, DT ;
Johnsen, H ;
Akslen, LA ;
Fluge, O ;
Pergamenschikov, A ;
Williams, C ;
Zhu, SX ;
Lonning, PE ;
Borresen-Dale, AL ;
Brown, PO ;
Botstein, D .
NATURE, 2000, 406 (6797) :747-752
[36]  
PRASAD GL, 1992, CELL GROWTH DIFFER, V3, P507
[37]   Life at the Leading Edge [J].
Ridley, Anne J. .
CELL, 2011, 145 (07) :1012-1022
[38]   A human breast cell model of preinvasive to invasive transition [J].
Rizki, Aylin ;
Weaver, Valerie M. ;
Lee, Sun-Young ;
Rozenberg, Gabriela I. ;
Chin, Koei ;
Myers, Connie A. ;
Bascom, Jamie L. ;
Semeiks, Jeremy R. ;
Grate, Leslie R. ;
Man, I. Saira ;
Borowsky, Alexander D. ;
Jensen, Roy A. ;
Idowu, Michael O. ;
Chen, Fanqing ;
Chen, David J. ;
Petersen, Ole W. ;
Gray, Joe W. ;
Bissell, Mina J. .
CANCER RESEARCH, 2008, 68 (05) :1378-1387
[39]   Dominant-negative alleles of 14-3-3 proteins cause defects in actin organization and vesicle targeting in the yeast Saccharomyces cerevisiae [J].
Roth, D ;
Birkenfeld, J ;
Betz, H .
FEBS LETTERS, 1999, 460 (03) :411-416
[40]   Distribution and significance of 14-3-3σ, a novel myoepithelial marker, in normal, benign, and malignant breast tissue [J].
Simpson, PT ;
Gale, T ;
Reis, JS ;
Jones, C ;
Parry, S ;
Steele, D ;
Cossu, A ;
Budroni, M ;
Palmieri, G ;
Lakhani, SR .
JOURNAL OF PATHOLOGY, 2004, 202 (03) :274-285